title: Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse.
abstract: A mouse model of barbital-induced narcosis was used to examine the effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761), an extract devoid of terpene trilactones (CP 205), and three terpene trilactone constituents of the extract (ginkgolides A and B, bilobalide). Administration of sodium barbital (180 mg/kg, IP) to the mice caused narcosis, measured as a loss in righting reflex. Single injections of EGb 761 (25 and 50 mg/kg), given 60 min prior to sodium barbital, significantly shortened barbital-induced sleeping time, whereas these same doses of CP 205 were ineffective. Single injections of ginkgolide B (1 mg/kg) and bilobalide (2 and 5 mg/kg) significantly shortened sleeping time, whereas ginkgolide A was ineffective. The effects of ginkgolide B and bilobalide were reflected as increases in latency to onset of sleep and those of EGb 761, ginkgolide B, and bilobalide were correlated with decreases in the number of mice that slept. At the behavioral level, these potent in vivo effects of EGb 761, ginkgolide B, and bilobalide resemble those of certain antidepressants. At the molecular level, it is hypothesized that interactions with the picrotoxinin/TBPT site of GABA-regulated Cl- channels of the CNS may be involved. This information appears useful in explaining the clinically observed "vigilance-enhancing" and "antidepressant-like" actions of EGb 761.
authors.affiliation: Psypharm SA, Route de Port Brillet, La Brulatte, France.
authors.forename: D
authors.initials: D
authors.lastname: Brochet
authors.forename: R
authors.initials: R
authors.lastname: Chermat
authors.forename: F V
authors.initials: FV
authors.lastname: DeFeudis
authors.forename: K
authors.initials: K
authors.lastname: Drieu
mesh_terms: D000704:Analysis of Variance; D000758:Anesthesia; D000818:Animals; D001462:Barbital / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D005419:Flavonoids / Q000494:pharmacology*; D020441:Ginkgo biloba; D046934:Ginkgolides; D007274:Injections, Intraperitoneal; D007783:Lactones / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology*; D012890:Sleep / Q000187:drug effects; D013997:Time Factors; D000096983:Ginkgo Extract
chemical_list: D001462:Barbital; D002110:Caffeine; D004224:Diterpenes; D005419:Flavonoids; D046934:Ginkgolides; D007783:Lactones; D018696:Neuroprotective Agents; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract; C045856:ginkgolide B